Literature DB >> 29165839

Striatal dopamine in Parkinson disease: A meta-analysis of imaging studies.

Valtteri Kaasinen1,2,3, Tero Vahlberg4,5.   

Abstract

A meta-analysis of 142 positron emission tomography and single photon emission computed tomography studies that have investigated striatal presynaptic dopamine function in Parkinson disease (PD) was performed. Subregional estimates of striatal dopamine metabolism are presented. The aromatic L-amino-acid decarboxylase (AADC) defect appears to be consistently smaller than the dopamine transporter and vesicular monoamine transporter 2 defects, suggesting upregulation of AADC function in PD. The correlation between disease severity and dopamine loss appears linear, but the majority of longitudinal studies point to a negative exponential progression pattern of dopamine loss in PD. Ann Neurol 2017;82:873-882.
© 2017 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29165839     DOI: 10.1002/ana.25103

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  37 in total

Review 1.  Brain Theranostics and Radiotheranostics: Exosomes and Graphenes In Vivo as Novel Brain Theranostics.

Authors:  Minseok Suh; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2018-11-09

2.  Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies.

Authors:  Valtteri Kaasinen; Tuomas Kankare; Juho Joutsa; Tero Vahlberg
Journal:  J Nucl Med       Date:  2019-04-12       Impact factor: 10.057

Review 3.  Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.

Authors:  Ralph Buchert; Carsten Buhmann; Ivayla Apostolova; Philipp T Meyer; Jürgen Gallinat
Journal:  Dtsch Arztebl Int       Date:  2019-11-01       Impact factor: 5.594

Review 4.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

5.  MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling.

Authors:  Atsuhiro Fujita; Yuko Fujita; Yaoyu Pu; Lijia Chang; Kenji Hashimoto
Journal:  Psychopharmacology (Berl)       Date:  2019-08-15       Impact factor: 4.530

6.  Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.

Authors:  Julia Shirvan; Nathan Clement; Rong Ye; Samantha Katz; Aaron Schultz; Keith A Johnson; Teresa Gomez-Isla; Matthew Frosch; John H Growdon; Stephen N Gomperts
Journal:  Neurology       Date:  2019-06-26       Impact factor: 9.910

Review 7.  Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms.

Authors:  Cecilia Peralta; Antonio P Strafella; Thilo van Eimeren; Roberto Ceravolo; Klaus Seppi; Valtteri Kaasinen; Julieta E Arena; Stephane Lehericy
Journal:  Mov Disord Clin Pract       Date:  2021-11-15

8.  Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.

Authors:  Jared T Hinkle; Kate Perepezko; Kelly A Mills; Zoltan Mari; Ankur Butala; Ted M Dawson; Alexander Pantelyat; Liana S Rosenthal; Gregory M Pontone
Journal:  Parkinsonism Relat Disord       Date:  2018-08-22       Impact factor: 4.891

9.  Conditioning Against the Pathology of Parkinson's disease.

Authors:  Rehana K Leak
Journal:  Cond Med       Date:  2018-04-28

Review 10.  Dopamine transporter SPECT imaging in Parkinson’s disease and parkinsonian disorders

Authors:  Ümit Özgür Akdemir; Ayşe Bora Tokçaer; Lütfiye Özlem Atay
Journal:  Turk J Med Sci       Date:  2021-04-30       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.